NO179675C - Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse - Google Patents

Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse

Info

Publication number
NO179675C
NO179675C NO923794A NO923794A NO179675C NO 179675 C NO179675 C NO 179675C NO 923794 A NO923794 A NO 923794A NO 923794 A NO923794 A NO 923794A NO 179675 C NO179675 C NO 179675C
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
pyrimidine nucleoside
nucleoside derivatives
group
Prior art date
Application number
NO923794A
Other languages
English (en)
Norwegian (no)
Other versions
NO923794D0 (no
NO923794L (no
NO179675B (no
Inventor
Masakatsu Kaneko
Hitoshi Hotoda
Tomoyuki Shibata
Tomowo Kobayashi
Yoshihiro Mitsuhashi
Akira Matsuda
Takuma Sasaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO923794D0 publication Critical patent/NO923794D0/no
Publication of NO923794L publication Critical patent/NO923794L/no
Publication of NO179675B publication Critical patent/NO179675B/no
Publication of NO179675C publication Critical patent/NO179675C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
NO923794A 1991-09-30 1992-09-30 Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse NO179675C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25201591 1991-09-30

Publications (4)

Publication Number Publication Date
NO923794D0 NO923794D0 (no) 1992-09-30
NO923794L NO923794L (no) 1993-03-31
NO179675B NO179675B (no) 1996-08-19
NO179675C true NO179675C (no) 1996-11-27

Family

ID=17231394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923794A NO179675C (no) 1991-09-30 1992-09-30 Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse

Country Status (24)

Country Link
US (1) US5691319A (fr)
EP (1) EP0536936B1 (fr)
JP (1) JP2569251B2 (fr)
KR (1) KR100255491B1 (fr)
CN (1) CN1033227C (fr)
AT (1) ATE141281T1 (fr)
AU (1) AU654212B2 (fr)
BR (1) BR1100621A (fr)
CA (1) CA2079413C (fr)
CZ (1) CZ289477B6 (fr)
DE (1) DE69212759T2 (fr)
DK (1) DK0536936T3 (fr)
ES (1) ES2093211T3 (fr)
FI (1) FI105556B (fr)
GR (1) GR3020893T3 (fr)
HK (1) HK204296A (fr)
HU (2) HU221812B1 (fr)
IL (1) IL103301A (fr)
MX (1) MXPA92005623A (fr)
NO (1) NO179675C (fr)
NZ (1) NZ244574A (fr)
RU (1) RU2085557C1 (fr)
TW (1) TW205042B (fr)
ZA (1) ZA927474B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
GB9515279D0 (en) 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
AU720451B2 (en) * 1997-01-24 2000-06-01 Conpharma As Gemcitabine derivatives
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
WO2000067760A1 (fr) * 1999-05-11 2000-11-16 Sankyo Company, Limited Preparation de liposomes a base de medicaments antitumoraux liposolubles
JP3748536B2 (ja) * 2001-02-09 2006-02-22 三共株式会社 ピリミジンヌクレオシド誘導体の結晶
US6908906B2 (en) 2001-02-09 2005-06-21 Sankyo Company, Limited Crystalline forms of pyrimidine nucleoside derivative
US20050014716A1 (en) * 2003-05-21 2005-01-20 Wang Jin Wei Pancreatic cancer treatment
GB0328180D0 (en) * 2003-12-04 2004-01-07 Cyclacel Ltd Combination
TW200637870A (en) * 2005-01-31 2006-11-01 Taiho Pharmaceutical Co Ltd Novel pyrimidine nucleoside compound and salt thereof
GB0523041D0 (en) * 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
US20100216736A2 (en) * 2006-07-21 2010-08-26 Taiho Pharmaceutical Co., Ltd. 2'-cyanopyrimidine nucleoside compound
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
GB2459779A (en) * 2008-05-08 2009-11-11 Cyclacel Ltd Process for the preparation of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine
GB0808359D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
CA2725295C (fr) 2008-06-09 2016-11-08 Cyclacel Limited Combinaison de sapacitabine (cndac) et inhibiteurs de methyltransferase d'adn comme la decitabine et la procaine
RU2538593C2 (ru) * 2009-05-15 2015-01-10 Дельта-Флай Фарма, Инк. НОВЫЕ СТАБИЛЬНЫЕ КРИСТАЛЛЫ МОНОГИДРОХЛОРИДА 1-(2-β-D-АРАБИНОФУРАНОЗИЛ)ЦИТОЗИНА
ES2743691T3 (es) 2011-04-14 2020-02-20 Cyclacel Ltd Régimen de dosis para sapacitabina y decitabina en combinación para tratar la leucemia mieloide aguda
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
US9073960B2 (en) 2011-12-22 2015-07-07 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
MX352423B (es) * 2012-03-28 2017-11-24 Fujifilm Corp Sal de 1-(2-desoxi-2-fluoro-4-tio-beta-d-arabinofuranosil) citosina.
US9872874B2 (en) 2012-05-15 2018-01-23 Cyclacel Limited Dosage regimen for sapacitabine and seliciclib
HRP20211456T1 (hr) * 2014-12-26 2021-12-24 Emory University Protuvirusni derivati n4-hidroksicitidina
US12071450B2 (en) 2015-12-03 2024-08-27 Biosight Ltd. Salts of conjugates for cancer therapy
RU2747528C2 (ru) * 2015-12-03 2021-05-06 Биосайт Лтд. Соли конъюгатов для лечения рака
US11058701B2 (en) 2015-12-03 2021-07-13 Biosight Ltd. Cytarabine conjugates for cancer therapy
US12064445B2 (en) 2015-12-03 2024-08-20 Biosight Ltd. Cytarabine conjugates for cancer therapy
WO2019081951A1 (fr) 2017-10-27 2019-05-02 Cyclacel Limited Régime posologique
KR102248165B1 (ko) 2017-12-07 2021-05-06 에모리 유니버시티 N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法
WO2021079129A1 (fr) 2019-10-24 2021-04-29 Cyclacel Limited Régime posologique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
WO1985000608A1 (fr) * 1983-07-20 1985-02-14 Teijin Limited Agent antineoplastique
US4818750A (en) * 1985-09-17 1989-04-04 Burroughs Wellcome Co. Treatment of human viral infections
ZA886890B (en) * 1987-10-09 1989-05-30 Hoffmann La Roche Novel dideoxycytidine derivatives
FR2640267B2 (fr) * 1988-01-19 1992-02-14 Univ Paris Curie Procede de synthese de l'azido-3(prime)-desoxy-3(prime)-thymidine et analogues
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
FR2632442B1 (fr) * 1988-06-06 1990-09-14 Framatome Sa Dispositif de mesure de parametres dans le coeur d'un reacteur nucleaire en service
EP0348170A3 (fr) * 1988-06-21 1990-12-05 Moses Nam Fong Lee Dérivés antiviraux de pyrimidine
FR2635778A1 (fr) * 1988-08-26 1990-03-02 Ire Celltarg Sa Nouveaux derives de la 3(prime) azido-3(prime) deoxythymidine (azt) actifs contre le virus hiv du sida
JPH0678338B2 (ja) * 1988-09-09 1994-10-05 帝人株式会社 ２′，３′−ジデオキシシチジン−２′−エン誘導体、その製造方法及びそれを有効成分とする抗レトロウイルス剤
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体

Also Published As

Publication number Publication date
FI924381A (fi) 1993-03-31
RU2085557C1 (ru) 1997-07-27
AU2602692A (en) 1993-04-01
KR100255491B1 (ko) 2000-05-01
IL103301A0 (en) 1993-02-21
CA2079413C (fr) 2003-09-09
CN1033227C (zh) 1996-11-06
ES2093211T3 (es) 1996-12-16
NO923794D0 (no) 1992-09-30
DK0536936T3 (da) 1997-01-13
HU221812B1 (hu) 2003-01-28
EP0536936A1 (fr) 1993-04-14
CA2079413A1 (fr) 1993-03-31
ATE141281T1 (de) 1996-08-15
CZ289477B6 (cs) 2002-01-16
HUT62310A (en) 1993-04-28
NZ244574A (en) 1994-01-26
HU211851A9 (en) 1995-12-28
BR1100621A (pt) 1999-12-07
DE69212759T2 (de) 1997-04-03
CZ298592A3 (en) 1993-12-15
KR930006045A (ko) 1993-04-20
EP0536936B1 (fr) 1996-08-14
NO923794L (no) 1993-03-31
HK204296A (en) 1996-11-15
IL103301A (en) 1997-07-13
FI105556B (fi) 2000-09-15
JPH05194497A (ja) 1993-08-03
FI924381A0 (fi) 1992-09-29
ZA927474B (en) 1993-07-14
CN1072686A (zh) 1993-06-02
MXPA92005623A (es) 2002-06-19
TW205042B (fr) 1993-05-01
AU654212B2 (en) 1994-10-27
NO179675B (no) 1996-08-19
GR3020893T3 (en) 1996-11-30
US5691319A (en) 1997-11-25
DE69212759D1 (de) 1996-09-19
JP2569251B2 (ja) 1997-01-08
HU9203115D0 (en) 1992-12-28

Similar Documents

Publication Publication Date Title
NO179675C (no) Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse
NO992549D0 (no) Sukkerforbindelse, geleringsmiddel og fremgangsmÕte for fremstilling derav
SE8804609D0 (sv) Adenosine derivatives
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
UA27220C2 (uk) Спосіб одержання похідних 1-фенілімідазолін-2,5-діону
EP0191496A3 (en) Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component
DK0609289T3 (da) Imidazolderivater og farmaceutiske præparater med indhold deraf
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
TW259785B (en) Chemical compounds
EP0598910A4 (fr) Procede de production de derive de nucleosides.
AU590793B2 (en) Phenoxy pthalide derivatives
EP1069126A4 (fr) Derives de triazolopurine, composition medicinale contenant lesdits derives, agent de compatibilisation de recepteur de l'adenosine a3, et medicament contre l'asthme
DK480389A (da) Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet
CA2244662A1 (fr) Antifongiques
ATE189813T1 (de) Prostaglandin-i-analoga
IL95929A0 (en) Inosine/guanosine derivatives and compositions containing them
MY104164A (en) Heterocyclic compounds.
TH17780A (fr)

Legal Events

Date Code Title Description
MK1K Patent expired